Most cited papers from PMG Research

PMG Research

What are the most cited papers from PMG Research?

The most cited paper from PMG Research is "Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults" (Carlos A. DiazGranados, Andrew J. Dunning, Murray A. Kimmel et al., 2014), with 894 citations. Next come "Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years" (178) and "Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance" (165).

Published TypeFieldAccessCitations

Showing 29 of 29 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults Carlos A. DiazGranados, Andrew J. Dunning, Murray A. Kimmel et al. · New England Journal of Medicine Open access	13 Aug 2014	894
2	Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years Brandon J. Essink, Charu Sabharwal, Kevin P. Cannon et al. · Clinical Infectious Diseases Open access	22 Dec 2021	178
3	Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance Paul D. Thompson, John Rubino, Matthew James Janik et al. · Journal of clinical lipidology Open access	29 Mar 2015	165
4	Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial Guy de Bruyn, Jamshid Saleh, David A. Workman et al. · Vaccine Open access	22 Mar 2016	97
5	Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial John Rubino, Diane Elaine MacDougall, Lulu Ren Sterling et al. · Atherosclerosis	30 Dec 2020	95
6	A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination Kevin P. Cannon, Charles R. Elder, Mariano M. Young et al. · Vaccine	25 Nov 2021	87
7	Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial John Rubino, Diane Elaine MacDougall, Lulu Ren Sterling et al. · Journal of clinical lipidology Open access	28 May 2021	72
8	The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial Robert C. Frederich, Robert McNeill, Niklas Berglind et al. · Diabetology & Metabolic Syndrome Open access	24 Jul 2012	66
9	Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study Stephan Bart, Kevin P. Cannon, Darrell T. Herrington et al. · Human Vaccines & Immunotherapeutics Open access	20 Jun 2016	58
10	Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Ellen J. Kim et al. · JAMA Dermatology Open access	20 Jul 2022	55
11	Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study Steven J. Russell, Robert D. Sala, Philip G. Conaghan et al. · Lara D. Veeken Open access	6 Aug 2018	43
12	REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients David M. Weinreich et al. · medRxiv PreprintOpen access	21 May 2021	40
13	Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine David Fitzpatrick, Donald S McVinnie, Lisa A. Jackson et al. · New England Journal of Medicine Open access	19 Nov 2025	33
14	Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial Kevin P. Cannon, José F. Cardona, Kari Yacisin et al. · Vaccine Open access	22 Feb 2023	32
15	The Life Cycle and Management of Protocol Deviations Munish Mehra, Katharina Kurpanek, Maryrose Petrizzo et al. · Therapeutic Innovation & Regulatory Science	18 Apr 2014	25
16	Spatio-temporal variation in the diet composition of red lionfish, Pterois volitans (Actinopterygii: Scorpaeniformes: Scorpaenidae), in the Mexican Caribbean: Insights into the ecological effect of the alien invasion Alfrancis Teresa Arredondo-Chávez, Julio Sánchez-Jiménez, Oscar Gabriel Ávila-Morales et al. · Acta Ichthyologica Et Piscatoria Open access	30 Sep 2016	20
17	Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis Robert Yapundich, Angela Applebee, François Béthoux et al. · International Journal of MS Care Open access	10 Oct 2014	17
18	BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double‐Blind Randomised Interventional Phase 2b Trial Roger A. Fielding et al. · Journal of Cachexia Sarcopenia and Muscle Open access	3 Mar 2025	15
19	Physiologically based pharmacokinetic model for ethyl tertiary‐butyl ether and tertiary‐butyl alcohol in rats: Contribution of binding to α2u–globulin in male rats and high‐exposure nonlinear kinetics to toxicity and cancer outcomes Susan J. Borghoff, Caroline Ring, Marcy I. Banton et al. · Journal of Applied Toxicology Open access	24 Nov 2016	9
20	Relationships between Height, Diameter, and Crown for Eastern Cottonwood (Populus Deltoides) in a Great Plains Riparian Ecosystem Thomas B. Lynch, Chakra B. Budhathoki, Robert F. Wittwer · Western Journal of Applied Forestry Open access	Oct 2012	8
21	A Novel Approach for Converting a Mandibular Complete Denture to a Fixed Interim, Screw‐Retained Implant Prostheses: A Case Report Brandon Kofford, Carl J Drago, Amir Hossein Nejat et al. · Journal of Prosthodontics	16 Nov 2020	7
22	Man vs. Machine - Measuring People for the Apparel Industry Warren Wright Conference paperOpen access	17 Oct 2019	2
23	Impact of Integrated Management Systems on Commercial Performance and Operational Processes in Sports Venues Vitaliy Zarubin · Universal Library of Innovative Research and Studies Open access	16 Jul 2025	0
24	Omega-3 Fatty Acids in Cancer: Insight into the Mechanism of Actions in Preclinical Cancer Models Asavari Joshi, Mahabaleshwar Vishnu Hegde, Sharad P. Adekar Book chapter	2025	0
25	Nutrition, Life, Disease, and Death Mahabaleshwar Vishnu Hegde, Anand A. Zanwar, Sharad P. Adekar Book chapter	2025	0
26	Gender Considerations and Omega-3 Fatty Acids in Cardiovascular Disease Sharad P. Adekar, Anand A. Zanwar, Mahabaleshwar Vishnu Hegde et al. Book chapter	2025	0
27	CHECKER: Real-time Scan Quality Checking and Associated User Experience Matthew S. GILMER, Steven C. HAUSER, David BRUNER Conference paperOpen access	4 Oct 2023	0
28	Trends In Patient Centered Research In The Published Literature Deborah L. Covington, KM Veley, Henry W. Williams · Value in Health Open access	May 2015	0
29	1102Immunogenicity and Safety of a Second Administration of 13-Valent Pneumococcal Conjugate Vaccine Five Years after Initial Vaccination in Adults 50 Years and Older Robert W. Frenck, Anne Fiquet, Alejandra Gurtman et al. · Open Forum Infectious Diseases Open access	2014	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.